Sweden's Sigrid Therapeutics has partnered with a multinational consumer health player to develop and commercialize its SiPore® technology in oral care. The deal includes upfront, milestone payments, and royalties, allowing Sigrid to expand its platform without diverting resources from its metabolic health products.
Sigrid Therapeutics enters exclusive global partnership to commercialize SiPore® in oral care
January 21, 2026